$ACOG.v / $ACOGF $ACOG.v / $ACOGF is a biopharmaceutical company currently in clinical trial for their ALPHA-1062, treating under-served neurodegenerative diseases.
https://www.youtube.com/watch?v=-QQSJNvmUuc&ab_channel=RadiusResearch
Here’s a great video to get acquainted with $ACOG.v they’ve been getting a lot of good press recently and for good reason.
APLHA-1062 potentially proving to be the best in its class with patients 45% of whom cannot have acetylcholinesterase inhibitor (AChEI) drugs due to stomach problems.
“Alpha Cognition is de-risked, late stage, and offers a unique combination of high reward with less-than-usual risk thanks to the well-established AChEI market and our evaluation of its preclinical and clinical data in the context of a 505(b)(2) pathway to approval,” Stellick wrote.
https://www.cantechletter.com/2021/12/three-canadian-biopharma-stocks-for-2022/#